Imamura, H., Furukawa, H. Iijima, S., Sugihara, S., Tsujinaka, T. Tsukuma, H. and Shimokawa, T(2007). Multicenter phase II study of 2 weeks administration with TS-1 followed by 1 week rest against metastatic gastric cancer, Hepatogastroenterology.